QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:US20160083365A1
公开(公告)日:2016-03-24
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:
where A, B, W
1
, W
2
, W
3
, and R
1
-R
6
are described herein.
这项发明涉及对突变异构异柠檬酸脱氢酶(mt-IDH)蛋白的抑制剂,具有新陈代谢活性,可用于治疗细胞增殖紊乱和癌症,其化学式为:其中A、B、W1、W2、W3和R1-R6如本文所述。